The global chemotherapy-induced thrombocytopenia therapeutics market size was valued at USD 1,550 million in 2021 and is projected to reach around USD 2,200 million in 2030 exhibiting a CAGR of 5.0% in the forecasted period.
The report titled “Chemotherapy-induced Thrombocytopenia Therapeutics Market” has recently been added by We Market Research to get a...
Chemotherapy Induced Thrombocytopenia (CIT) refers to a condition of low platelet count caused due to chemotherapy treatment for cancer. Chemotherapy induced thrombocytopenia therapeutics includes various drugs and medications that help manage platelet count and assist in blood clotting during chemotherapy. Some commonly used chemotherapy induced thrombocytopenia therapeutics include...